Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $377.95, with a market capitalization of 204B. The stock trades at a price-to-earnings (P/E) ratio of 23.44 and offers a dividend yield of 2.63%.
On 2026-09-12, Amgen(AMGN) stock traded between a low of $377.21 and a high of $387.97. Shares are currently priced at $377.95, which is +0.2% above the low and -2.6% below the high.
The Amgen(AMGN)'s current trading volume is 2.27M, compared to an average daily volume of 2.77M.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
AMGN News
...
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? 8/27/2026 Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease t...
Key Points Amgen maintains a massive global footprint and generated over $8.1 billion in free cash flow during its latest fiscal year. Revolution Medicines is...
Analyst ratings
56%
of 36 ratingsMore AMGN News
In early trading on Friday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a Phase 4 trial called “A Trial Assessing the Effectivenes...
HSBC analyst Morten Herholdt last night downgraded Amgen (AMGN) to Hold from Buy with a price target of $425, down from $445. After re-rating on Amgen’s strong...
📣 “This is the worst possible outcome for Amgen.” —Barclays analyst Emily Field, on Novartis announcing a disappointing result for its heart disease drug, a di...
The Dow Jones Industrial Average (^DJI -1.18%) fell 1.18% to 52,786, the S&P 500 (^GSPC -0.58%) lost 0.58% to 7,674, and the Nasdaq Composite (^IXIC -0.32%) dro...
The S&P 500 (SPX) closed down 0.55% on Monday amid higher oil prices and elevated rate hike expectations. Let’s break down the sectors behind the performance....
Amgen Inc. (NASDAQ:AMGN) cratered 9.8% to $394.56 Tuesday, on track for its worst single-day loss since October 2000. The damage came from a rival. Novartis A...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.